Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
barrier decrease » barrier disease (Expand Search), marked decrease (Expand Search), barrier creates (Expand Search)
larger decrease » marked decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
barrier decrease » barrier disease (Expand Search), marked decrease (Expand Search), barrier creates (Expand Search)
larger decrease » marked decrease (Expand Search)
-
3721
Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness.
Published 2024Subjects: -
3722
-
3723
-
3724
-
3725
-
3726
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3727
-
3728
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
3729
-
3730
-
3731
-
3732
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
3733
-
3734
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
3735
Relative abundance of microbiota in colonic content at the genus level (n = 5).
Published 2025Subjects: -
3736
-
3737
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
3738
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: -
3739
-
3740
Potential metabolites in the colonic tissue related with diarrhea induced by FSE.
Published 2025Subjects: